Press release
Cell and Gene Therapy Supply Chain Software Market Insights Show Rapid Digital Transformation in Cold Chain Logistics and Biopharmaceutical Operations
Cell and gene Therapy Supply Chain Software Market
The Cell & Gene Therapy Supply Chain Software Market is poised for significant growth, projected to surpass USD 668.4 Mn by 2031, with a promising CAGR of 13.9% during the forecast period.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2520
Innovative therapeutic modalities, such as cell and gene therapies, are reshaping the landscape of modern healthcare. The increasing adoption of these advanced treatments has significantly accelerated progress in drug development, biomanufacturing processes, and patient care delivery. These novel therapies enable clinicians to address rare and complex diseases more effectively, thereby broadening the spectrum of available treatment options.
The associated supply chain ecosystem is supported by specialized software platforms that facilitate efficient inventory control, logistics management, temperature-sensitive transportation, and adherence to regulatory standards. These digital solutions enhance operational efficiency and improve collaboration among critical stakeholders, including manufacturers, contract research organizations (CROs), logistics providers, and healthcare facilities.
Continued investment in research and development (R&D) is pivotal to fostering innovation and enhancing the quality and scalability of therapeutic production. The long-term market outlook remains robust, underpinned by the increasing integration of digital technologies across the value chain.
List of Prominent Key Players in the Cell and Gene Therapy Supply Chain Software Market:
• Azenta Life Sciences
• Biocair
• BioLife Solutions
• CareDx
• Cryoport
• Lonza
• NMDP BioTherapies
• TraceLink
• TrakCel
• Veeva Systems
• Emerson
• LabVantage Solutions
• Marken
• MasterControl
• QuickSTAT
• Siemens
• Stafa Cellular Therapy
• Steiner
• STEMSOFT Software
• TECHNICAL
• Thermo Fisher Scientific
• Other Prominent Players
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
Market Dynamics: Cell and Gene Therapy Supply Chain Software
Drivers
The growth of the cell and gene therapy supply chain software market is primarily driven by the increasing demand for personalized medicine and advanced therapeutic modalities. The intricate nature of cell and gene therapy manufacturing necessitates the deployment of specialized software to preserve product integrity, ensure regulatory compliance, and streamline logistics operations.
The expanding number of clinical trials and the commercialization of these therapies further amplifies the need for robust supply chain management tools capable of addressing complex operational challenges. Additionally, the COVID-19 pandemic highlighted vulnerabilities in global supply chains, thereby accelerating the adoption of digital solutions that enhance resilience, transparency, and efficiency.
Challenges
Despite the market's positive outlook, several challenges persist. High development and implementation costs of specialized supply chain software pose financial constraints, particularly for smaller enterprises. Regulatory complexity and rigorous compliance requirements add further difficulty to the development and integration of these solutions.
Moreover, interoperability limitations among disparate systems often hinder seamless data sharing and end-to-end visibility across the supply chain. The rapid pace of technological advancement and evolving industry standards require continuous updates and improvements, creating additional operational and financial burdens for software providers and users.
Regional Trends
North America continues to lead in the biotechnology and pharmaceutical sectors, supported by a robust network of research institutions, biopharmaceutical firms, and advanced manufacturing capabilities specific to cell and gene therapy. The region also benefits from the presence of prominent technology firms and software developers, reinforcing its leadership in supply chain innovation.
Stakeholders, including regulatory bodies and industry participants, must remain aligned with these regional developments to inform strategic planning and support the ongoing evolution of supply chain solutions within the cell and gene therapy landscape.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2520
Recent Developments:
• In January 2024, Veeva Systems partnered with SK Biopharmaceuticals to optimize the former company's quality management system and decrease the risks involved with quality assurance of regenerative healthcare medicine.
• In Nov 2023, Cryoport, Inc. announced its acquisition of Tec4med LifeScience GmbH. Cryoport's acquire of Tec4med is a significant step in broadening their range of condition monitoring solutions, fostering new product development, and accelerating European market penetration, notably in the DACH area (Germany, Austria, Switzerland).
• In June 2023, Biocair has integrated TrakCel's software with OCELLOS to increase customer service, automation, and visibility in the cell and gene therapy (CGT) supply chain.TrakCel's advanced therapeutic orchestration platform OCELLOS streamlines the cell, gene, and immunotherapy supply chain. To scale cell and gene therapy development, the platform tracks chain of identification and custody. This lets stakeholders track orders in transit.
Segments of Cell and Gene Therapy Supply Chain Software Market -
By Process Component-
• Sample Collection and Processing Component
• Manufacturing Component
• Logistics Component
• Patient Identification and Treatment Follow-up Component
By Type of Software-
• Enterprise Manufacturing System (EMS)
• Laboratory Information Management System (LIMS)
• Inventory Management System (IMS)
• Cell Orchestration Platform (COP)
• Quality Management System (QMS)
• Logistics Management System (LMS)
• Patient Management System (PMS)
By Mode of Deployment-
• On-premises Deployment
• Cloud-based Deployment
By Type of End-User-
• Pharmaceutical Companies
• Cell Therapy Labs
• Hospitals / Medical Centers
• Research Institutes / Biobanks
By Scale of Operation-
• Clinical Scale
• Commercial Scale
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/cell-and-gene-therapy-supply-chain-software-market/2520
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cell and Gene Therapy Supply Chain Software Market Insights Show Rapid Digital Transformation in Cold Chain Logistics and Biopharmaceutical Operations here
News-ID: 4032685 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
6G Market expected to Witness Huge Revenue Growth to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global 6G Market Size, Share & Trends Analysis Report By Devices (Mobile Devices, IoT and Edge-Computing Devices, Networking Devices), Communication Infrastructure (Wireless And Fixed) And End Users (Consumer Applications And Industrial And Enterprise)- Market Outlook And Industry Analysis 2035"
The global 6G market is estimated to reach over USD 159.54 billion by 2035, exhibiting a CAGR of…
5G Non-Terrestrial Networks Market Current Scenario with Future Trends Analysis …
"5G Non-Terrestrial Networks Market" in terms of revenue was estimated to be worth $ 5.5 billion in 2024 and is poised to reach $192.0 billion by 2034, growing at a CAGR of 43.1% from 2025 to 2034 according to a new report by InsightAce Analytic.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1921
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the 5G non-terrestrial networks market are:
• Technological advancement
• High network…
Over The Counter Tests Market Exclusive Report on Current Trends and Future Insi …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Over The Counter Tests Market Size, Share & Trends Analysis Report By Technology (Lateral Flow Assays, Immunoassays, Dipsticks), By Product (Infectious Disease Tests, Glucose Monitoring Tests, Pregnancy and Fertility Tests), Region, Market Outlook And Industry Analysis 2031"
The Global Over The Counter Tests Market is estimated to reach over USD 43.40 billion by 2031, exhibiting a…
Artificial Intelligence in Cardiology Market is on an Upward Growth Curve
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Artificial Intelligence in Cardiology Market Size, Share & Trends Analysis Report By Component (Hardware, Services), By Application (Stroke, CHD/CAD), Region, Market Outlook And Industry Analysis 2031"
The global artificial intelligence in cardiology market is estimated to reach over USD 11.5 billion by 2031, exhibiting a CAGR of 32.70% during the forecast period.
Request For Free Sample…
More Releases for Cell
Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting.
Download Full PDF Sample Copy…
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
